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This article summarizes basic information about the up to date treatment modalities of
asymptomatic abdominal aortic aneurysm (AAA). It is based on data from recent respected
publications, randomized studies and on European as well as American guidelines
published by dedicated professional associations. The main aim is to clarify the differences
in results of conservative, endovascular and open surgical treatment and also to present an
objective view about the indication of optimal treatment modality for individual patients
with AAA.
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z.o.o. All
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Abdominal aortic aneurysm (AAA) is defined as a focal
dilation of the abdominal aorta 1.5 times greater than normal
width, below the origin of the renal arteries. A commonlyech Society of Cardiology
2.accepted term for AAA is dilation of the aorta greater than
Z3 cm [1,2] and is mostly (80%) located between the origin of
renal arteries and the aortic bifurcation. Despite the advances
in modern medicine, the mortality of ruptured AAA remains
very high (40–70%) [3] and represents the 14th most common. Published by Elsevier Urban & Partner Sp.z.o.o. All rights
Table 1 – Risk of AAA rupture in one year, determined by
outer diameter of the aneurysm (ESVS—European
Society for Vascular Surgery [15], SVS—Society for Vas-
cular Surgery [16]).
12-month of risk of AAA rupture (%) according to the AAA
diameter







c o r e t v a s a 5 4 ( 2 0 1 2 ) e 2 5 3 – e 2 5 7e254cause of death in USA [4]. The only causal therapy to prevent
rupture is endovascular or open repair. The main diagnostic
criterion for non-conservative treatment (endovascular/open
repair) is the outer width of the aneurysm. Surgical or
endovascular interventions are usually considered if the
dilation of the aorta is Z5.5 cm (Z5.0 cm in women) without
age limitation. This fact is based on comparative studies
which monitored patients diagnosed with AAA. The results
have shown that in 5-year follow up the patients with
AAAZ5.5 cm have 25–40% risk of rupture compared to 1–7%
for patients with AAAo5.0 cm [4–6]. The aim of this article,
based on most up to date studies, is to try to objectively
describe the treatment modalities and their respective
indications.Table 2 – Expected patient survival (in yr) after surgical
repair of AAA according to age, sex and race.
Age Total Men Women
Caucasian Other Caucasian Other
60 13 12 11 14 13
65 11 11 10 12 11
70 10 9 8 10 10
75 8 8 7 9 8
80 6 6 6 7 6
Z85 5 4 4 5 52. Conservative treatment
Patients, who undergo elective surgical treatment (open
repair) for asymptomatic AAA will also face considerable
risks of intraoperative and postoperative complications. On
the other hand, these risks dramatically increase with acute
rupture followed by surgery. The mortality of ruptured AAA is
somewhere between 50% and 90% in contrast to 1–5% with
elective procedure in patients with asymptomatic aneurysms
[7]. The conservative approach mainly focuses on reducing
the risks of cardiovascular disease as well as on pharmaco-
logical treatment of hypertension and must be indicated
strictly individually. The main criteria are—small diameter
of AAA, slow progression of dilation, poor health condition of
the patient and at last the evaluation of the risk benefit
assessment of radical treatment for an individual patient. As
stated above, the key factor in decision making is the
diameter of the aneurysm itself. The conservative approach
is indicated, based on the results of multiple studies—ADAM
[8], CAESAR [9], PIVOTAL [10] and UKSAT [11], in female
patients with diameter o5.0 cm and in men o5.5 cm.
The progression of dilation though, cannot exceed
Z0.5 cm/1/2 year. In these so called ‘‘small’’ but progressive
aneurysms, there is a risk of rupture of 60–65% in 5 years and
70–75% in 8 years [11,12]. Besides the small aneurysms, which
do not fulfill the criteria for invasive treatment, there are
patients who benefit from conservative approach due to a
high risk of open repair surgery and also technically impos-
sible endovascular treatment. The evaluation of intraopera-
tive risks is described later on. A very important factor when
considering conservative treatment is the comparison of life
expectancy of a patient with or without intervention. A
typical example of this patient is an 85 year old man with
5.5 cm AAA, high risk of surgery and technically impossible
endovascular approach.
The risk of rupture in 1 year for this patient is described as
3–15% (Table 1). According to the studies which have com-
pared the overall survival rate after successful open/endo-
vascular repair of AAA, this patient has an expected survival
of only 5 years (Table 2) [13,14]. Thus in this case the
conservative treatment has a greater benefit for the patient
than a demanding surgical treatment, burdened by high risks
of postoperative complications. An important part of the
conservative approach is regular control of hypertensionand ultrasound follow up of the progression of the AAA.
The interval was determined by the American College of
Cardiology (ACC/AHA) [2] as follows: once in 2 years for AAA
from 3.0 to 3.9 cm and once a year in AAAZ4.0 cm.3. Surgical treatment
Invasive treatment (endovascular/open repair) is indicated in
all symptomatic patients (abdominal pain, back pain caused
by blood leakage from the aneurysm or thromboembolic
disease) and of course in ruptured AAA. In asymptomatic
AAA we indicate surgery if the width of aneurysm is above
5.5 cm in men and 5 cm in women. The indication criteria for
surgical treatment according to European and American
professional medical organizations are shown in Table 3. In
an open repair, tubular or bifurcated prosthesis are used in
bypassing the aneurysm. Up-to-date randomized studies
show 30-day perioperative mortality range from 2.7 to 5.8%
[12,17]. Another invasive option is endovascular implantation
of a coated stent (EVAR, Endo Vascular Aneurysm Repair) into
the sack of the aneurysm eliminating it from the circulation.
According to the National Institute for Health and Clinical
Excellence Statement from 2012 (NHS) [18] the patient must
meet special criteria for EVAR implantation (Table 4). The
technical success rate of EVAR is stated as high as 83–95%
[19,20] and 30-day mortality of 1.6% [21]. The EVAR technique
offers a short operating time, the possibility of local
Table 4 – Guidance refers for EVAR implantation accord-
ing to NHS 2012 (NHS—National Institute for Health and
Clinical Excellence).
Patients with unruptured infra-renal abdominal aortic aneurysms,
for whom surgical intervention is considered appropriate
Suitable aneurysm size and morphology
Assessment of the short- and long-term benefits and risks for
EVAR versus open surgery
Endovascular aneurysm repair should only be performed in
specialist centers by clinical teams experienced in the
management of abdominal aortic aneurysms
Endovascular aortic stent–grafts are not recommended for
patients with ruptured aneurysms except in the context of
research
Table 3 – Indication criteria for surgical treatment of AAA
(ESVS—European Society for Vascular Surgery [15], ACC/
AHA—The American College of Cardiology/American
Heart Association, CSVS—The Canadian Society for
Vascular Surgery [2]).
ESVS ACC/AHA
Men with AAAZ55 mm Men/womenZ55 mm
Men with AAAZ50 mm with
high risk of rupture
Men/women with
symptomatic AAA




Men/women fast growing AAA
(Z1 cm/year)
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 2 5 3 – e 2 5 7 e255anesthesia, shorter convalescents and is less demanding for
the patient [22].
3.1. Comparing the results of open surgical repair to
endovascular stenting
The enthusiasm accompanying the EVAR method, which
seemed to be an ideal mini invasive and low risk treatment,
led to a significant decrease of open repair surgeries in many
centers. An objective view on EVAR has been recently pre-
sented by randomized studies, which compared it to open
repair (OR) of AAA. The main up to date studies which focus
on patients with sub renal AAA greater than 50 mm, are
DREAM, EVAR1 and ACE. The main inclusion criterion was
that the patients would be suitable for both EVAR and open
repair. The first results of the DREAM study (The Dutch
Randomized Endovascular Aneurysm Management) which
randomized 351 patients, were published in 2004 and have
shown significantly lower 30-day mortality for EVAR (1.2%
EVAR vs. 4.6% OR) [23]. However the results of two year follow
up, published in 2005 have not demonstrated any difference
between overall mortality (20.4% EVAR vs. 20.3% OR). The
EVAR study randomized 1082 patients with the same inclu-
sion criteria like a DREAM study. The primary target was tocompare an overall 4-year mortality. No differences were
found in endovascular or open repair; both had mortality
around 28%. The 3% difference in operative mortality in EVAR
compared to OR (1.7% EVAR vs. 4.7% OR) was confirmed also
after a 4-year follow up (26% EVAR vs. 29% OP; P¼.04). The
studies have also demonstrated disadvantages of EVAR. By
four years postoperative complications in the EVAR group
were observed in 41% as opposed to 9% in the OR group, re-
interventions were 20% vs. 6% and EVAR proved costlier by
1/3. The EVAR1 study did not demonstrate a difference in life
quality after 12 months in the groups [24]. The last published
study, in 2011, is a French randomized ACE (Aneurysme de
l’aorte abdominale: Chirurgie vs. Endoprothese). The study
included 316 patients with asymptomatic AAA45 cm. So far,
during the three years follow up period there have not been
demonstrated differences in survival rates or serious compli-
cations between EVAR and OR. (95.971.6% vs. 93.272.1% in
first year and 85.174.5% vs. 82.473.7% in 3 years (P¼.09)). A
statistically important difference between mortality during
hospitalization (0.6% vs. 1.3%; P¼1.0) or in minor postopera-
tive complications was also not shown. Similarly to the
EVAR1 and DREAM, this study also proved more percentage
of re-interventions in EVAR (2.4% vs. 16%, Po.0001) and lesser
percentage of death related to aneurysm (0.7% vs. 4%; P¼.12)
in the EVAR group [25]. The results of these studies suggest
that EVAR is suitable for patients, who cannot undergo open
repair due to high risk of postoperative complications.
3.2. Indications for open surgical and endovascular repair
The decision concerning the indication of open or endovas-
cular repair of AAA treatment is often discussed in multi-
disciplinary specialist groups at many of our vascular centers.
The method of choice is often based on the experience or the
habits of specific departments. Nevertheless the objective
decision should be made based on extended knowledge of
the results of the mentioned randomized studies hand in
hand with the experience of the center. In general we can
conclude that all studies recommend EVAR as the method of
choice for patients with high risk for open surgery. The extent
of risk of open repair is generally described as low, medium
and high, but the understanding of the term ‘‘surgical risk’’ is
often very subjective and inaccurate. All clinicians wish for
an objective pre-operative evaluation which would define the
surgical risk for AAA in order to choose the best option for the
patient. There have already been some studies which tried to
objectively describe the surgical risk of AAA open repair. The
aim was to program a scoring system based on the input
patient data that would predict the mortality and possible
likelihood of postoperative complications after elective sur-
gical treatment of AAA. In 2004 Nesi [26], in his work
compared the 5 most common scoring systems (Eagle score
[27], Glasgow aneurysm score [28], Leiden score [29], modified
Leiden score [30], Vanzetto score [31]) in prediction of opera-
tive mortality and early major complications in 286 patients
after elective surgery. Even though this work was a retro-
spective analysis all of these scores, it showed a good
predictive power in postoperative mortality, but lower pre-
dictive power in postoperative complications. The most
known scoring system is the Glasgow aneurysm score
Fig. 1 – Algorithm for establishing the indication for open or
endovascular treatment.
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 2 5 3 – e 2 5 7e256(GAS). The calculation is based on counting the points for age
added with points for three main comorbidities (þ7pts. for
chronic ischemic heart disease (CD): myocardial infarc-
tionþangina pectoris in patient history, þ10pts. for cerebro
vascular disease (CVD): all types of strokes and transitory
ischemic attacks, þ14pts. for renal disease (RD): chronic or
acute renal failure or urea420 mmol/l and/or creatinin4150
mmol/l). From GAS calculation (GAS¼ageþ(7pts. CD)þ(10pts.
CVD)þ(14 RD)) we can quickly obtain the value, which
expresses the extend of surgical risk and major complica-
tions. Patients who score 479 pts. have statistically
higher risk of death and complications than those below
79 pts. According to ACC/AHA [2] recommendations, the
patients with low and medium risk should be operated and
those with high risk treated by EVAR. The algorithm for
indication for open or endovascular treatment is depicted in
Fig. 1.4. Conclusion
The evaluation of the rupture risk of AAA, the surgical risk,
predicted life expectancy, anatomical relations of AAA
together with patient’s preferences all in context with vast
knowledge of recent study findings, suggest a good chance to
make the correct decision for the optimal treatment for
patients with asymptomatic AAA. On the other hand, the
uneasy decision for the conservative approach proved to be,
in selected indications, the best option and demonstrates
ones extended knowledge and professional skill. An indis-
pensable factor for the successful treatment is also the
concentration of patients in specialized centers with experi-
ence with AAA.Acknowledgment
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